The C3-activator system: an alternate pathway of complement activation - PubMed (original) (raw)
. 1971 Sep 1;134(3 Pt 2):90s-108s.
- PMID: 4105810
The C3-activator system: an alternate pathway of complement activation
O Götze et al. J Exp Med. 1971.
No abstract available
Similar articles
- Isolation of the sixth component of complement from human serum.
Arroyave CM, Müller-Eberhard HJ. Arroyave CM, et al. Immunochemistry. 1971 Nov;8(11):995-1006. doi: 10.1016/0019-2791(71)90487-3. Immunochemistry. 1971. PMID: 4110102 No abstract available. - Purification of human C3 proactivator by affinity chromatography.
Auderset MJ, Lambert PH, Miescher PA. Auderset MJ, et al. Immunochemistry. 1974 Apr;11(4):207-11. doi: 10.1016/0019-2791(74)90330-9. Immunochemistry. 1974. PMID: 4137147 No abstract available. - Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them.
Ballow M, Cochrane CG. Ballow M, et al. J Immunol. 1969 Nov;103(5):944-52. J Immunol. 1969. PMID: 4981797 No abstract available. - Purification and some properties of a heat labile serum factor (UP); identity with glycine-rich beta-glycoprotein and properdin factor B.
Lynen R, Brade V, Wolf A, Vogt W. Lynen R, et al. Hoppe Seylers Z Physiol Chem. 1973 Jan;354(1):37-47. doi: 10.1515/bchm2.1973.354.1.37. Hoppe Seylers Z Physiol Chem. 1973. PMID: 4214745 No abstract available. - The structure of the fibrinogen degradation products.
Marder VJ, Budzynski AZ. Marder VJ, et al. Prog Hemost Thromb. 1974;2(0):141-74. Prog Hemost Thromb. 1974. PMID: 4137300 Review. No abstract available.
Cited by
- Animal toxins - Nature's evolutionary-refined toolkit for basic research and drug discovery.
Herzig V, Cristofori-Armstrong B, Israel MR, Nixon SA, Vetter I, King GF. Herzig V, et al. Biochem Pharmacol. 2020 Nov;181:114096. doi: 10.1016/j.bcp.2020.114096. Epub 2020 Jun 12. Biochem Pharmacol. 2020. PMID: 32535105 Free PMC article. Review. - Antibody and complement-dependent viral neutralization.
Cooper NR, Welsh RM Jr. Cooper NR, et al. Springer Semin Immunopathol. 1979;2(3):285-310. doi: 10.1007/BF00198721. Springer Semin Immunopathol. 1979. PMID: 32214620 Free PMC article. No abstract available. - Nanoparticle Vaccines Against Infectious Diseases.
Pati R, Shevtsov M, Sonawane A. Pati R, et al. Front Immunol. 2018 Oct 4;9:2224. doi: 10.3389/fimmu.2018.02224. eCollection 2018. Front Immunol. 2018. PMID: 30337923 Free PMC article. Review. - Binding of Soluble Yeast β-Glucan to Human Neutrophils and Monocytes is Complement-Dependent.
Bose N, Chan AS, Guerrero F, Maristany CM, Qiu X, Walsh RM, Ertelt KE, Jonas AB, Gorden KB, Dudney CM, Wurst LR, Danielson ME, Elmasry N, Magee AS, Patchen ML, Vasilakos JP. Bose N, et al. Front Immunol. 2013 Aug 12;4:230. doi: 10.3389/fimmu.2013.00230. eCollection 2013. Front Immunol. 2013. PMID: 23964276 Free PMC article. - Delta inulin: a novel, immunologically active, stable packing structure comprising β-D-[2 -> 1] poly(fructo-furanosyl) α-D-glucose polymers.
Cooper PD, Petrovsky N. Cooper PD, et al. Glycobiology. 2011 May;21(5):595-606. doi: 10.1093/glycob/cwq201. Epub 2010 Dec 7. Glycobiology. 2011. PMID: 21147758 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous